A Concise Book of Pharma Career Paths after Graduation, Edition 1 | Book Publisher International

This book, A Concise Book of Pharma Career Paths After Graduation, serves as a comprehensive guide for pharmacy graduates exploring their professional options. It delves into the diverse career paths available in the field of pharmacy, spanning community and hospital pharmacy, the pharmaceutical industry, academia, research, government roles, clinical research, consulting, and entrepreneurship. Each chapter provides insights into the responsibilities, required skills, and growth potential associated with these roles. Additionally, it offers guidance on career planning, addresses common doubts, and explores future trends in the profession. Designed to inspire and inform, this book equips readers with the knowledge to make informed decisions about their pharmacy career while emphasizing adaptability and lifelong learning in an evolving healthcare landscape.

 

Author (s) Details

 

Mr. Shivanand Kolageri
Department of Pharmaceutical Chemistry, BLDEA’s SSM College of Pharmacy and Research Centre, Vijayapura, Karnataka, India.

 

Dr. Muragesh Pattanshetti
Department of Management, BLDEA’s A S Patil College of Commerce (Autonomous), Vijayapura, Karnataka, India.

 

Dr. Chetankumar. S.M.
Department of Pharmaceutics, BLDEA’s SSM College of Pharmacy and Research Centre, Vijayapura, Karnataka, India.

 

Dr. Mallinath V Paramagond
Department of Pharmacy Practice, BLDEA’s SSM College of Pharmacy and Research Centre, Vijayapura, Karnataka, India.

 

Please see the book here:- https://doi.org/10.9734/bpi/mono/978-81-982889-0-5

Heart Failure and Its Treatment with Trimetazidine | Chapter 7 | Advanced Concepts in Pharmaceutical Research Vol. 6

This review summarizes the basic pathological changes in the myocardium, with an emphasis on the alteration of cardiac metabolism in the development of heart failure. Trimetazidine was shown to directly improve myocardial metabolism by modulating beta oxidation, rather than by indirectly improving the hemodynamics. Heart failure can be attributed to various pathogenic reasons and is a systemic syndrome. The results of current therapy are not satisfactory. Trimetazidine has been shown in several fundamental investigations to have a heart-protective action that involves reducing inflammation, autophagy, fibrosis, and myocardial apoptosis in addition to altering metabolism. Clinical studies have consistently indicated that trimetazidine acts as an adjunct to conventional treatments and improves the symptoms of heart failure. The clinical application of trimetazidine in heart failure and the mechanism of its protective effects on the myocardium are carefully discussed, as well as its main adverse effects. Non-ischemic heart failure has a variety of causes, including diabetes and hypertension; therefore, specific treatments targeting the causes may provide more promising outcomes than simply relieving the symptoms of heart failure. The intention of this review is to highlight this treatment as an effective alternative against heart failure and provide additional perspectives for future studies.

Author(s) Details:

Hongyang Shu,
Division of Cardiology, Department of Internal Medicine, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China and Hubei Key Laboratory of Genetics and Molecular Mechanism of Cardiologic Disorders, Huazhong University of Science and Technology, Wuhan, China.

Yizhong Peng,
Department of Orthopaedics, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.

Weijian Hang,
Division of Cardiology, Department of Internal Medicine, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China and Hubei Key Laboratory of Genetics and Molecular Mechanism of Cardiologic Disorders, Huazhong University of Science and Technology, Wuhan, China.

Ning Zhou,
Division of Cardiology, Department of Internal Medicine, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China and Hubei Key Laboratory of Genetics and Molecular Mechanism of Cardiologic Disorders, Huazhong University of Science and Technology, Wuhan, China.

Daowen Wang,
Division of Cardiology, Department of Internal Medicine, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China and Hubei Key Laboratory of Genetics and Molecular Mechanism of Cardiologic Disorders, Huazhong University of Science and Technology, Wuhan, China.

Please see the link here: https://stm.bookpi.org/ACPR-V6/article/view/13465

The Autonomic, Hormonal, and Immunological Contributions to the Metabolism and Control of Adipose Tissue as an Organ | Chapter 11 | Emerging Trends in Disease and Health Research Vol. 5

 White adipose tissue (WAT) has traditionally been thought of as a passive storage deposit of surplus lipid as an energy reserve. Recent research, however, reveals that WAT functions as an organ system, interacting with the autonomic neural, endocrine, and immune systems. As a result, WAT may operate as a regulatory organ that aids in the maintenance of homeostasis in the body. This cross-sectional study analyses physiological data from 30 patients at the Pinewood Natural Health Centre in Toronto, Canada, to describe the role of WAT in homeostasis mediation. Statistical methods generate a formula that describes the dynamic congruence, which adds to an understanding of the organism through systems medicine (SM). Multiple variables were examined and associated using multiple regression analysis, including body metrics, body composition, metabolic parameters, heart rate variability, and the immunological, autonomous, neurological, and endocrine systems. The null hypothesis stated that no variables would correlate; the alternative hypothesis stated that at least two variables would correlate to indicate congruence and order. The current study aimed to see if different markers of endocrine, metabolic, anthropometric, and immunological functioning linked with evidence supporting the WAT as a contributor to homeostasis. The findings of this investigation revealed high relationships with immune system and metabolism markers, but just a few with the autonomous nervous system. This implies that, despite the body's complexity, not all systems contribute equally heavily to general homeostasis, but that the WAT mass plays an important role in sustaining homeostasis.

Author(S) Details

Michael S. Rahman
Division of Biomedical Sciences, Colleges of Medicine and Graduate Studies, University of Science Arts and Technology, Montserrat, BWI, USA.

George P. Einstein
Einstein Medical Institute, North Palm Beach, USA.

Orien L. Tulp
Pinewood Natural Health Centre, Ontario, Canada.

View Book:- https://stm.bookpi.org/ETDHR-V5/article/view/6149

Study on Genome Sequencing Practices as Driving Force of Clinical Research Modernization in the Future | Chapter 10 | Issues and Development in Health Research Vol. 3

 Genome sequencing is one of the most recent technologies to be incorporated into medical practises for disease diagnosis and medication development studies. It's frequently used in genomic medicine to process and analyse information about genes and markers in order to diagnose and cure disease. Genomic medicine, in particular, use DNA and RNA platform sequencing technologies to examine the human genome for mutations and molecular abnormalities with evident clinical implications that may be linked to uncommon genetic illnesses. With the help of these genomic sequencing platforms, the Human Genome Sequencing Project, which discovered roughly 35,000 genes in sequences of more than 3 billion human DNA and RNA chemical bases, was finished in 2003. (first- and second-generation sequencing technologies). This paved the path for genomic medicine, allowing researchers to undertake translational genomic clinical trials, which have improved the clinical trial process in a number of ways.

Author (S) Details

Yawo M. Akrodou
Department of Health Science, Walden University, USA.

View Book :- https://stm.bookpi.org/IDHR-V3/article/view/3304

A Reports and Review on Colorectal Cancer Metastases to the Thyroid Gland | Chapter 2 | Highlights on Medicine and Medical Science Vol. 10

 Background: Thyroid gland secondary cancers are a rare occurrence in clinical practise. In addition, colorectal metastasis to the thyroid (CMT) is an extremely rarer occurrence. The primary tumor's origins follow demographic and ethnical patterns, reflecting the most common cancers in various communities. One of the most common types of cancer is colorectal cancer. Despite the fact that cancer is common all over the world, CMT is rarely identified. The majority of them are discovered during the course of treatment for gastrointestinal primary cancers. Survival and, as a result, identification of metastatic disease has become more common as imaging methods, oncological treatment, and follow-up have improved. Due to the paucity of information and the challenges in conducting clinical trials and research, these facts make this entity a diagnostic and therapeutic challenge. Case Summary: This is a case report of a patient who was diagnosed with a CMT of rectum adenocarcinoma four years after neoadjuvant chemoradiotherapy, subsequent curative surgical resection of the main tumour, and intercurrent lung bilateral metastases. Conclusions: Thyroid metastases of extrathyroid origin are infrequent, and extremely rarer when CMT is taken into account. The diagnostic method, as well as oncologic patient survival, is improving, and as a result, the frequency of thyroid gland metastases is increasing. The patient was diagnosed with a CMT of rectum adenocarcinoma four years after neoadjuvant chemoradiotherapy, curative surgical removal of the main tumour, and intercurrent lung bilateral metastases. Conclusions: Thyroid metastases from outside the thyroid are uncommon, and much rarer when CMT is taken into account. The diagnostic approach, as well as oncologic patient survival, are improving, and as a result, thyroid gland metastases are becoming more common.

Author (S) Details

Patricia Ciriano Hernández
Department of Surgery, Hospital General Universitario de Ciudad Real, Ciudad Real 13005, Castilla La Mancha, Spain.

View Book :- https://stm.bookpi.org/HMMS-V10/article/view/2250